isomethyleugenol has been researched along with Cancer of Endometrium in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (8.33) | 18.2507 |
| 2000's | 7 (19.44) | 29.6817 |
| 2010's | 8 (22.22) | 24.3611 |
| 2020's | 18 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Fang, X; Guo, Q; Miao, C; Zhao, Y | 1 |
| Hu, Y; Li, H; Liu, P; Sun, L; Tian, C; Yan, F; Zhang, Z; Zhuang, Y | 1 |
| Honjoh, H; Inoue, F; Iriyama, T; Kukita, A; Kusakabe, M; Miyamoto, Y; Nishijima, A; Oda, K; Osuga, Y; Sone, K; Taguchi, A; Takahashi, Y; Tanikawa, M; Tanimoto, S; Toyohara, Y; Tsuruga, T; Uchino, MM; Wada-Hiraike, O | 1 |
| Chen, Z; Dong, H; Sun, Y; Xu, H; Zhang, F; Zhang, J | 1 |
| Guo, X; Lu, R; Shi, Y; Wu, Q; Yang, J; Ye, G; Zeng, Y | 1 |
| Chen, Q; Guo, J; Lv, N; Shen, S; Tong, J | 1 |
| Chen, J; Luo, X; Wang, G; Zhang, J; Zhang, Y | 1 |
| Chen, J; Chen, S; Chen, X; Liu, X; Lu, B; Qin, H; Zhao, Y | 1 |
| Fang, F; Huang, H; Li, Q; Liu, X; Wang, P; Ye, M | 1 |
| Liang, S; Ni, J; Ren, Y; Shan, B; Tian, W; Wang, H | 1 |
| Chen, F; Hao, W; Jiang, M; Lin, J; Liu, B; Sun, D; Tang, C; Xing, H; Yang, J; Yu, M; Zhang, X; Zhao, Y; Zhu, Y | 1 |
| Hara, A; Inoue, F; Kukita, A; Osuga, Y; Sone, K; Taguchi, A; Takahashi, Y; Tanikawa, M; Toyohara, Y; Tsuruga, T | 1 |
| Cheng, Y; Dong, Y; Fan, Y; Li, X; Wang, J; Wang, Z; Yang, X; Zhou, J | 1 |
| Ma, J; Ma, XX; Yang, D | 1 |
| Tang, X; Wu, W; Wu, Y; Zhou, J; Zhu, W | 1 |
| Yang, Y; Zhang, Y | 1 |
| Huang, Y; Pang, X; Qian, S; Zhang, X | 1 |
| Yang, P; Yun, K; Zhang, R | 1 |
| Cheng, A; Garbett, NC; Merchant, ML; Petkowski, JJ; Schaner Tooley, CE; Shields, KM; Tooley, JG; Wilkey, DW | 1 |
| Cao, J; Chen, SM; Chryplewicz, A; Eckert, MA; Harada, BT; He, C; Huang, JT; Leng, XH; Lengyel, E; Liu, J; Liu, SM; Lu, Z; Tienda, SM; Xu, ZG; Yang, Y; Yu, K; Yu, XC; Zhang, Z; Zhu, AC | 1 |
| Bail, S; Bhaskar, A; Nestor, M; Pusey, M; Rice, LM; Wandzioch, E; Werda, A; Yang, JJ | 1 |
| Bearss, J; Gajiwala, S; Janat-Amsbury, M; Sharma, S; Sorna, V; Theisen, ER | 1 |
| Gao, X; Ma, CX; Ma, X; Patriub, V; Sklar, JL; Wang, J | 1 |
| Bao, W; Chen, C; Liu, Y; Wang, S; Wang, Y; Wu, S; Xu, Y; Zhang, J; Zhang, Z | 1 |
| Aarnio, M; Abdel-Rahman, WM; Bützow, R; Gylling, A; Järvinen, HJ; Mecklin, JP; Nieminen, TT; Nuorva, K; Peltomäki, P; Renkonen-Sinisalo, L | 1 |
| Clayton, AC; Distad, TJ; Halling, KC; Kerr, SE; Kipp, BR; Medeiros, F; Peterson, LM; Smith, DI | 1 |
| Bosse, T; Creutzberg, CL; Jobsen, JJ; Jürgenliemk-Schulz, IM; Lutgens, LC; Nout, RA; Smit, VT; Ter Haar, NT; van der Steen-Banasik, EM; van Eijk, R | 1 |
| Hirai, Y; Takeshima, N | 1 |
| Inoue, M; Kanaya, T; Kyo, S; Maida, Y | 1 |
| Abdel-Rahman, WM; Butzow, R; Järvelä, I; Kariola, R; Lindroos, A; Moisio, AL; Ollikainen, M; Peltomäki, P; Pöyhönen, M | 1 |
| Desmond, JC; Gery, S; Jones, PA; Kawamata, N; Koeffler, HP; Miyakawa, I; Popoviciu, LM; Said, JW; Takai, N; Walsh, CS; Whittaker, S | 1 |
| Hashimoto, M; Inoue, M; Kanaya, T; Kyo, S; Maida, Y; Mizumoto, Y; Nakamura, M; Sakaguchi, J; Takakura, M | 1 |
| Motegi, A; Nakajima, T; Nakayama, H; Oyama, T; Sano, T | 1 |
| Altaras, M; Ben-Baruch, G; Klein, Z; Kloog, Y; Marciano, D; Solomon, R | 1 |
| Baylin, SB; Ellenson, LH; Esteller, M; Herman, JG; Levine, R | 1 |
| Bocker, T; Fishel, R; Gersell, DJ; Goodfellow, PJ; Kovatich, AJ; Mutch, DG; Palazzo, JP; Simpkins, SB; Swisher, EM | 1 |
3 review(s) available for isomethyleugenol and Cancer of Endometrium
| Article | Year |
|---|---|
Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications.
Topics: Acetylation; Chromatin Immunoprecipitation Sequencing; Disease Progression; DNA Methylation; Endometrial Neoplasms; Epigenesis, Genetic; Female; Gene Expression Regulation; Histones; Humans; Methylation; Neoplasm Recurrence, Local; RNA, Untranslated | 2021 |
[Genetic abnormalities in endometrial cancer].
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Carrier Proteins; Cell Division; Endometrial Neoplasms; Female; Gene Silencing; Genes, p53; Genes, Tumor Suppressor; Genomic Instability; Humans; Loss of Heterozygosity; Methylation; Microsatellite Repeats; Mutation; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Promoter Regions, Genetic; PTEN Phosphohydrolase; Signal Transduction; Tumor Suppressor Proteins | 2004 |
[Genetic diagnosis of endometrial cancer].
Topics: Adaptor Proteins, Signal Transducing; Carrier Proteins; DNA Repair; Endometrial Neoplasms; Female; Genomic Instability; Humans; Methylation; Microsatellite Repeats; Mutation; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Promoter Regions, Genetic; PTEN Phosphohydrolase; Sequence Analysis, DNA; Telomerase; Tumor Suppressor Proteins | 2004 |
33 other study(ies) available for isomethyleugenol and Cancer of Endometrium
| Article | Year |
|---|---|
Identification of an eight-m6A RNA methylation regulator prognostic signature of uterine corpus endometrial carcinoma based on bioinformatics analysis.
Topics: Biomarkers, Tumor; Computational Biology; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methyltransferases; Neoplasm Proteins; Nomograms; Prognosis; RNA; RNA, Neoplasm; Survival Rate | 2021 |
Molecular mechanisms and differences in lynch syndrome developing into colorectal cancer and endometrial cancer based on gene expression, methylation, and mutation analysis.
Topics: Colorectal Neoplasms, Hereditary Nonpolyposis; Endometrial Neoplasms; Female; Gene Expression; Humans; Methylation; Microsatellite Instability; Mutation; MutL Protein Homolog 1 | 2022 |
Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer.
Topics: Apoptosis; Arginine; CARD Signaling Adaptor Proteins; Endometrial Neoplasms; Female; Guanylate Cyclase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Methylation; Protein-Arginine N-Methyltransferases | 2022 |
circRNA circRIMS Downregulates miR-505 through Methylation to Suppress Cell Proliferation in Endometrial Cancer.
Topics: Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Methylation; MicroRNAs; RNA, Circular | 2022 |
Circular RNA circSEPT9 Is Upregulated in Endometrial Cancer and Promotes Cell Invasion and Migration by Downregulating miR-186 through Methylation.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA Methylation; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; MicroRNAs; Neoplasm Invasiveness; RNA, Circular; Septins | 2022 |
RNA m6A methylation regulators in endometrial cancer (Review).
Topics: Adenosine; Endometrial Neoplasms; Female; Humans; Methylation; Methyltransferases; RNA; RNA, Messenger | 2022 |
Analysis of m
Topics: Endometrial Neoplasms; Epigenesis, Genetic; Eukaryota; Female; Humans; Methylation; Tumor Microenvironment | 2023 |
C/D box small nucleolar RNA SNORD104 promotes endometrial cancer by regulating the 2'-O-methylation of PARP1.
Topics: Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Poly (ADP-Ribose) Polymerase-1; Protein Processing, Post-Translational; RNA Stability; RNA, Messenger; RNA, Small Nucleolar | 2022 |
m
Topics: Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Genes, Regulator; Humans; Methylation; Prognosis; RNA | 2022 |
Methylation‑associated silencing of miR‑638 promotes endometrial carcinoma progression by targeting MEF2C.
Topics: Animals; Apoptosis; Base Sequence; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Disease-Free Survival; Down-Regulation; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; MEF2 Transcription Factors; Methylation; Mice; Mice, Nude; MicroRNAs; Promoter Regions, Genetic | 2020 |
The pan-cancer landscape of netrin family reveals potential oncogenic biomarkers.
Topics: Biomarkers, Tumor; Endometrial Neoplasms; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Kaplan-Meier Estimate; Methylation; Mutation Rate; Neoplasms; Netrins; Quantitative Trait Loci | 2020 |
A ten-gene methylation signature as a novel biomarker for improving prediction of prognosis and indicating gene targets in endometrial cancer.
Topics: Biomarkers, Tumor; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Prognosis | 2021 |
Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Topics: Adenosine; Cell Line, Tumor; Cell Proliferation; Disease-Free Survival; DNA Copy Number Variations; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Ligands; Lymphocytes, Tumor-Infiltrating; Methylation; Middle Aged; Molecular Docking Simulation; Mutation; Neoplasm Invasiveness; Neoplasm Proteins; Prognosis; Proportional Hazards Models; RNA, Messenger; Small Molecule Libraries; Tumor Microenvironment | 2021 |
Overexpression of circRNA circFAT1 in Endometrial Cancer Cells Increases Their Stemness by Upregulating miR-21 Through Methylation.
Topics: Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Humans; Methylation; MicroRNAs; RNA, Circular | 2022 |
Effects of m6A RNA methylation regulators on endometrial cancer.
Topics: Adenine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Case-Control Studies; Endometrial Neoplasms; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Methylation; Prognosis; RNA; Survival Rate | 2021 |
A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma.
Topics: Adenosine; Biomarkers, Tumor; China; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Methylation; Middle Aged; Nomograms; Predictive Value of Tests; Prognosis; Proportional Hazards Models; RNA; Survival Analysis | 2021 |
CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation.
Topics: Endometrial Neoplasms; Female; Humans; Methylation; MicroRNAs; RNA, Circular | 2021 |
Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N-terminal trimethylation.
Topics: A549 Cells; Amino Acid Substitution; Biocatalysis; Catalytic Domain; Cell Cycle Proteins; Crystallography, X-Ray; Endometrial Neoplasms; Female; Gene Expression; Guanine Nucleotide Exchange Factors; HCT116 Cells; HEK293 Cells; Histidine; Humans; Isoenzymes; Kinetics; Lung Neoplasms; Male; Methylation; Methyltransferases; Models, Molecular; Mutation; Neoplasm Proteins; Nuclear Proteins; Oligopeptides; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Recombinant Fusion Proteins; Substrate Specificity | 2017 |
m
Topics: Adenosine; Animals; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Mechanistic Target of Rapamycin Complex 2; Methylation; Methyltransferases; Mice, Nude; Mutation; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-akt; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Time Factors; Tumor Burden | 2018 |
PME-1 modulates protein phosphatase 2A activity to promote the malignant phenotype of endometrial cancer cells.
Topics: Animals; Carboxylic Ester Hydrolases; Cell Growth Processes; Endometrial Neoplasms; Female; Heterografts; Humans; Methylation; Mice; Mice, Nude; Phenotype; Protein Phosphatase 2; Signal Transduction | 2014 |
Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Disease Models, Animal; Dose-Response Relationship, Drug; Endometrial Neoplasms; Female; Histone Demethylases; Histones; Humans; Methylation; Mice; Neoplasm Grading; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
The JAZF1-SUZ12 fusion protein disrupts PRC2 complexes and impairs chromatin repression during human endometrial stromal tumorogenesis.
Topics: Animals; Cell Differentiation; Cell Line; Chromatin; Chromatin Assembly and Disassembly; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 7; Co-Repressor Proteins; DNA-Binding Proteins; Endometrial Neoplasms; Epigenetic Repression; Female; HEK293 Cells; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Mice; Neoplasm Proteins; Polycomb Repressive Complex 2; Recombinant Fusion Proteins; Transcription Factors; Translocation, Genetic | 2017 |
LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromones; Cyclin D1; Endometrial Neoplasms; Estradiol; Estrogens; Female; G1 Phase Cell Cycle Checkpoints; Histone Demethylases; Histones; Humans; Methylation; Middle Aged; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Promoter Regions, Genetic; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptors, Estrogen; Receptors, G-Protein-Coupled; RNA Interference; RNA, Small Interfering | 2017 |
Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.
Topics: Adult; Aged; Biomarkers, Tumor; Disease Progression; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Hyperplasia; Methylation; Middle Aged; Oligonucleotide Array Sequence Analysis | 2009 |
Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.
Topics: Adaptor Proteins, Signal Transducing; Aged; Class I Phosphatidylinositol 3-Kinases; Cohort Studies; DNA Mismatch Repair; DNA Mutational Analysis; DNA, Neoplasm; Endometrial Neoplasms; Female; Humans; Hydrolases; Methylation; Microsatellite Instability; Mutation; MutL Protein Homolog 1; Nuclear Proteins; Phosphatidylinositol 3-Kinases; Phosphotransferases; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; ras Proteins; Retrospective Studies; Tumor Suppressor Protein p53 | 2012 |
Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
Topics: Adaptor Proteins, Signal Transducing; Aged; Aged, 80 and over; beta Catenin; Disease-Free Survival; Endometrial Neoplasms; Exons; Female; Humans; Kaplan-Meier Estimate; Methylation; Microsatellite Instability; Middle Aged; Multivariate Analysis; Mutation; MutL Protein Homolog 1; Neoplasm Recurrence, Local; Nuclear Proteins; Promoter Regions, Genetic; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); PTEN Phosphohydrolase; ras Proteins; Risk Assessment; Sequence Analysis, DNA; Transcription Factors; Tumor Suppressor Protein p53; Wnt Signaling Pathway | 2012 |
Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Carrier Proteins; Colorectal Neoplasms, Hereditary Nonpolyposis; DNA-Binding Proteins; Endometrial Neoplasms; Female; Humans; Immunohistochemistry; Loss of Heterozygosity; Methylation; Middle Aged; Mutation, Missense; MutL Protein Homolog 1; MutS Homolog 2 Protein; MutS Homolog 3 Protein; Neoplasm Proteins; Nuclear Proteins; Proto-Oncogene Proteins; Syndrome | 2005 |
Discovery of epigenetically masked tumor suppressor genes in endometrial cancer.
Topics: Aged; Aged, 80 and over; CCAAT-Enhancer-Binding Protein-alpha; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Endometrial Neoplasms; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Histones; Humans; Mediator Complex; Methylation; Middle Aged; Transcription Factors | 2005 |
Association of mismatch repair deficiency with PTEN frameshift mutations in endometrial cancers and the precursors in a Japanese population.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Aged, 80 and over; Base Pair Mismatch; Base Sequence; Carrier Proteins; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Frameshift Mutation; Humans; Immunohistochemistry; Japan; Methylation; Microsatellite Repeats; Middle Aged; MutL Protein Homolog 1; Neoplasm Proteins; Nuclear Proteins; Phosphoric Monoester Hydrolases; Polymerase Chain Reaction; Precancerous Conditions; Promoter Regions, Genetic; PTEN Phosphohydrolase; Tumor Suppressor Proteins | 2005 |
Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma.
Topics: 14-3-3 Proteins; Adenocarcinoma; Adolescent; Adult; Biomarkers, Tumor; Cell Cycle; Disease Progression; DNA-Binding Proteins; Endometrial Neoplasms; Endometrium; Estrogen Receptor alpha; Exonucleases; Exoribonucleases; Female; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Lymphatic Metastasis; Menstrual Cycle; Methylation; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Polymerase Chain Reaction; Transcription Factors; Tripartite Motif Proteins; Tumor Protein p73; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2005 |
Characterization of the prenylated protein methyltransferase in human endometrial carcinoma.
Topics: Endometrial Neoplasms; Endometrium; Female; GTP-Binding Proteins; Humans; Kinetics; Methylation; Protein Methyltransferases; Subcellular Fractions; Substrate Specificity | 1994 |
MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas.
Topics: Adaptor Proteins, Signal Transducing; Carrier Proteins; DNA-Binding Proteins; Endometrial Neoplasms; Female; Humans; Methylation; Microsatellite Repeats; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Phenotype; Proto-Oncogene Proteins | 1998 |
MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.
Topics: Adaptor Proteins, Signal Transducing; Carrier Proteins; DNA-Binding Proteins; Endometrial Neoplasms; Female; Gene Expression Regulation; Humans; Immunohistochemistry; Methylation; Microsatellite Repeats; MutL Protein Homolog 1; MutS Homolog 2 Protein; Neoplasm Proteins; Nuclear Proteins; Promoter Regions, Genetic; Proto-Oncogene Proteins | 1999 |